📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) (2022)

First Author: Vivaldi G

Attributed to: BREATHE - The Health Data Research Hub for Respiratory Health funded by ISCF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100501

Publication URI: http://dx.doi.org/10.1016/j.lanepe.2022.100501

Type: Journal Article/Review

Parent Publication: The Lancet Regional Health - Europe